According to researchers at Tulane University, Stanford University, and the Centers for Disease Control and Prevention, vesper bats carry two distinct copies of the genes involved in producing antibodies, a genetic configuration never before seen in any other known mammal. Published in Science Advances, the finding offers a fresh clue as to how these flying mammals can host severe viral diseases without becoming seriously ill themselves.
How Vesper Bats Developed a Dual Antibody System
Vesper bats comprise a vast family of more than 500 species distributed across every continent except Antarctica. Hannah Frank, the corresponding author of the study and an associate professor of ecology and evolutionary biology at the Tulane University School of Science and Engineering, noted that this finding completely upends how scientists view the arrangement of the mammalian immune system. While humans and all other known mammals rely on a single set of genes to build the heavy protein chains of Y-shaped antibodies, vesper bats possess two separate heavy-chain gene systems on two separate chromosomes.
Genetic analysis conducted in labs at Stanford University alongside CDC researchers revealed that these two gene sets serve distinct biological functions. In the big brown bat, a common North American species studied by the team, one gene set contains 33 antibody genes while the other holds 99. The first set undergoes heavy mutation and refinement to bind tightly to a single target, whereas the second set maintains more starting genes with less internal mutation to recognize a wider array of targets loosely. Despite having two distinct systems, individual immune cells do not attempt to use both simultaneously; instead, cells typically attempt rearrangement in one set first before moving to the second, keeping each antibody functional and distinct.
Did you know? Vesper bats also diverge from typical mammals in their light-chain proteins. The big brown bat synthesizes just a single variety of light chain, whereas most mammals can manufacture two; nevertheless, its lone light-chain gene family boasts over 100 functional genes, surpassing the combined total of both human light-chain families.
Evolutionary Success and the Broader Impact on Virology
The implications of this doubled antibody blueprint extend far beyond a single species. After examining the genomes of 26 related bat species, researchers found that nearly all of them carry the same doubled system, pointing to a single event deep in the family’s past that likely happened once in a shared ancestor, tens of millions of years ago. This long-standing genetic stability may help explain the remarkable evolutionary success of vesper bats over millennia.
While immunology research traditionally focuses on innate immunity in bats, Frank noted that this discovery shifts attention toward the adaptive immune system. Understanding how bats coexist with dangerous pathogens without succumbing to disease could eventually refine disease spillover reduction strategies and expand scientific knowledge beyond standard human and mouse models.
Frequently Asked Questions
What makes vesper bat immunity different from other mammals?
According to research published in Science Advances, vesper bats carry two separate sets of heavy-chain antibody genes on different chromosomes, whereas all other known mammals possess only a single set.
Which institutions collaborated on the bat immunity study?
The research was led by Tulane University with collaborators from Stanford University and the Centers for Disease Control and Prevention (CDC).
Do bats use both antibody gene sets at the same time in a single cell?
Does this discovery explain why bats carry viruses safely?
Not entirely. According to Hannah Frank, this discovery represents an important piece of the puzzle and reveals a hidden level of immune variety, though it does not yet fully explain why bats are such effective viral reservoirs.
Explore More: Want to stay updated on the latest breakthroughs in evolutionary biology and wildlife immunology? Subscribe to our newsletter or leave a comment below to join the discussion.
Related reading